Dr. Bernard M. Peperstraete is CEO and co-founder of Acuamark Diagnostics, Inc. Bernard is a medical entrepreneur, and has been involved in operating in, founding and investing in life science businesses for over 20 years; Prior to Acuamark, Bernard ran ACT Biotech, a cancer pharmaceutical company (acquired by Eddingpharm). Earlier, Bernard was involved in healthcare venture capital for nearly a decade, most recently as a Partner at NGN Capital. Bernard served on the boards of Exosome Diagnostics (acquired by Bio-Techne), ACT Biotech and Potentia Pharma (aka APLS:NASDAQ), and was closely involved with a number of transactions, e.g. Santhera (SANN:SIX) and Artisan Pharma (acquired by AKP). Before completing his MBA at Harvard, Bernard worked on emerging market opportunities at Novartis in Basel, was a Deputy Director at the Tan Tock Seng Hospital in Singapore (during the SARS crisis) and successfully co-founded and ran a contract research business, also in Singapore. In 1999, after serving as a physician, Dr. Peperstraete managed the HIV business unit at Bristol Myers & Squibb, Singapore. MD, Katholieke Universiteit Leuven, Belgium; DTMIH, Institute of Tropical Medicine, Belgium MBA, Harvard Business School.

Gene Godick is AcuamarkDx’s VP of Finance (consulting) and Treasurer. He has over 25 years of executive and financial experience, raising hundreds of millions of dollars in equity and debt financing, leading over fifty M&A transactions, and working with some of the top buy and sell side analysts on the “Street.” Today, he runs G-Squared Partners, providing outsourced CFO services and strategic financial, accounting, and operational expertise to CEOs, VC-backed start-ups and entrepreneurs. Gene started his career in Arthur Andersen’s Enterprise Group where he worked with emerging growth companies. While at Arthur Andersen, he was responsible for over 100 audits, 20 M&A transactions, and an initial public offering. Gene served as a senior manager at KPMG, during which he worked with clients including Safeguard Scientifics, Internet Capital Group, Primavera Software, US Interactive, Integrated Circuit Systems, Verticalnet, and Triton PCS. Gene was the EVP and CFO of Verticalnet and led its IPO in 1999, raising over $60-million, considered one of the most successful IPO’s of the internet era. During Gene’s tenure, the company raised well over $300-million and completed more than 25 acquisitions and divestitures.